AINewsBreaks Archive - Page 7 of 34

TuesdayJul 29, 2025 10:16 am

AINewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Reports Strong Shareholder Engagement in Virtual Teleconference Highlighting AI-Driven Growth Strategy

Fifty 1 Labs (OTC: FITY), a pioneer in AI-powered health and wellness solutions, successfully hosted its July 28 virtual shareholder teleconference via X (formerly Twitter), outlining its transformative strategy through subsidiary Fifty 1 AI Labs. CEO Paul Arora detailed the company’s AI-driven drug repurposing platform targeting the $320.6 billion functional medicine market and $5.68 trillion biotech sector, supported by a $350,000 personal investment and salary deferrals from management until reaching a $50 million valuation. Key initiatives include a $1 million R&D investment, a targeted $5–10 million biotech acquisition by 2027, and planned uplisting to OTCQB in 2026 and NASDAQ thereafter.…

TuesdayJul 29, 2025 9:45 am

AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Subsidiary FHVH to Showcase Robotics and AI Solutions at California Restaurant Show

Nightfood Holdings (OTCQB: NGTF), through its wholly owned subsidiary Future Hospitality Ventures Holdings Inc. (FHVH) doing business as RoboOp365, announced its participation in the California Restaurant Show from Aug. 3–5, 2025, at the Anaheim Convention Center. Exhibiting at booth 228, FHVH will feature live demonstrations of its AI-enabled kitchen operations and introduce components of its proposed joint venture with Los Angeles Cooking School to create the first U.S. culinary education platform fully integrated with AI, robotics, and automation systems. CEO Sonny Wang said the initiative reflects FHVH’s next phase of execution as it expands its footprint in the $400+ billion…

TuesdayJul 29, 2025 9:35 am

AINewsBreaks – Onar Holding Corporation (OTCQB: ONAR) Expands Strategic Partnership with IQSTEL (NASDAQ: IQST) to Launch AI-Driven Multi-Agentic Operating Infrastructure

Onar (OTCQB: ONAR), a marketing technology company and global agency network, announced an expanded partnership with IQSTEL, Inc. (NASDAQ: IQST) and its AI subsidiary Reality Border to develop a next-generation AI-driven, multi-agentic operating infrastructure. Building on ONAR’s 2024 rebranding of IQSTEL, the initiative will integrate dedicated AI agents for every ONAR employee and client account, streamlining operations, enhancing performance optimization, and enabling real-time strategic insights. CEO Claude Zdanow said the system amplifies human potential by automating repetitive processes while preserving data security. The three-phase rollout will introduce operational streamlining, strategic enablement, and creative augmentation, positioning ONAR at the forefront of…

MondayJul 28, 2025 10:46 am

AINewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) to Host July 28 Virtual Shareholder Teleconference Featuring Nobel Laureate Dr. James Orbinski

Fifty 1 Labs (OTC: FITY), a leader in AI-powered health and wellness solutions, announced it will host a virtual shareholder teleconference on Monday, July 28, 2025, at 12:00 PM EST. The event, streamed live on X (formerly Twitter), will feature Senior Scientist Dr. James Orbinski, who accepted the 1999 Nobel Peace Prize on behalf of Médecins Sans Frontières (Doctors Without Borders). The teleconference will highlight the company’s strategic roadmap for subsidiary Fifty 1 AI Labs, including AI-driven drug repurposing for functional medicine, a $1 million R&D investment, and plans for a $5–10 million biotech acquisition by 2027. Management underscored alignment…

MondayJul 28, 2025 9:00 am

AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence and genomic data to accelerate oncology drug discovery, announced the appointment of Lee T. Schalop, MD, to its Board of Directors. Dr. Schalop, co-founder and former CEO of Oncoceutics Inc., brings over 20 years of experience in biotechnology leadership and financial markets, with a track record in developing targeted therapies for solid tumors, including HK327M-mutant gliomas. Oncoceutics was acquired by Chimerix Inc. (NASDAQ: CMRX) for $450 million in 2021 and later by Jazz Pharmaceuticals for $935 million in April 2025. Lantern CEO Panna Sharma said Dr. Schalop’s expertise in…

ThursdayJul 24, 2025 3:06 pm

AINewsBreaks – Nightfood Holdings Inc.’s (NGTF) Dual Model Driving Next-Gen Hospitality

Nightfood Holdings (OTCQB: NGTF) was featured in a recent article that discusses its distinction in combining AI-powered robotics technology with strategic hotel acquisitions, expanding into new vision for next-generation solutions for the hospitality sector. The piece reads, “Rather than simply selling robotics solutions to third parties, the company owns and operates the hotels where its technology is implemented, creating multiple revenue streams while demonstrating real-world performance… Technology is transforming operational efficiency through robotic housekeeping solutions, a major addressing matter to the industry’s labor challenge. The increased demand for hotel automation, driven by staff shortages, is leading to greater use of robotic…

WednesdayJul 23, 2025 10:49 am

AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Reports First Complete Response in Phase 1 LP-284 Trial for Aggressive DLBCL

Lantern Pharma (NASDAQ: LTRN) announced a complete metabolic response in a heavily pretreated patient with aggressive Grade 3 non-germinal center B-cell DLBCL during its ongoing Phase 1 trial of LP-284—the first such response observed with the candidate. The patient had failed three prior regimens, including CAR-T and bispecific antibody therapy, before responding after just two cycles of LP-284, a next-generation acylfulvene developed using Lantern’s RADR(R) AI platform. This outcome highlights LP-284’s synthetic lethal mechanism and potential as a paradigm-shifting therapy for refractory lymphomas, supporting accelerated development and strategic expansion in the $4 billion global B-cell cancer market. To view the…

WednesdayJul 23, 2025 9:00 am

AINewsBreaks – BluSky AI Inc. (OTC: BSAI) CEO Featured on IBN’s GotStocks Podcast to Discuss Scalable AI Infrastructure Strategy

BluSky AI (OTC: BSAI) CEO Trent D’Ambrosio was featured on the latest episode of IBN’s GotStocks Podcast, where he outlined the company’s mission to deliver modular, high-performance AI infrastructure with dramatically shortened build times. D’Ambrosio highlighted BluSky’s focus on inference computing and its scalable, adaptive design approach, capable of delivering facilities in 12 to 18 months—far faster than industry norms. He emphasized the company’s readiness to evolve with the rapidly changing AI landscape, calling it “a very exciting time” for innovation and market expansion. To view the full press release, visit https://ibn.fm/pMpc1 About BluSky AI Inc. BluSky AI, headquartered in…

TuesdayJul 22, 2025 1:46 pm

AINewsBreaks – BluSky AI Inc. (OTC: BSAI) Appoints Andrea Huels as Chief AI and Growth Officer to Lead Modular Infrastructure Expansion

BluSky AI (OTC: BSAI), a leader in modular AI infrastructure, has named Andrea Huels as its new Chief AI and Growth Officer. Huels, a recognized authority in applied AI and edge computing, brings over 20 years of leadership across Fortune 500 companies and startups, including Lenovo, GE, and RadiusAI. She will drive BluSky’s AI strategy, ecosystem growth, and the expansion of its SkyMod modular data center platform. CEO Trent D’Ambrosio said Huels' arrival “marks a defining moment” for the company’s next phase of growth. To view the full press release, visit https://ibn.fm/qiNYo About BluSky AI Inc. BluSky AI, headquartered in…

TuesdayJul 22, 2025 10:00 am

AINewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Reports Strong Expectations for Quantum Computing-Based Optimization

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, released findings from a survey conducted with Wakefield Research showing rising enterprise interest in quantum optimization. The survey polled 400 business leaders, defined as logistics or operational managers and decision-makers who make decisions about optimization in their line-of-business. Of the business leaders surveyed who have implemented quantum optimization or plan to do so within the next two years, 46% expect return on investment (ROI) between $1 and $5 million within a year, while 27% anticipate an ROI exceeding $5 million within that time. The report highlights…

AINewsWire provides insights in the emerging sector of Artificial Intelligence.

Contact us: (512) 354-7000

AINewsBreaks